Results 311 to 320 of about 745,330 (389)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Sanctions

open access: yes, 1990
Jonathan Eaton, Maxim Engers
openaire   +1 more source

Reasons for insufficient compliance with infection prevention and control measures in the intensive care unit: a qualitative study conducted in Türkiye in 2024. [PDF]

open access: yesAntimicrob Resist Infect Control
Madran B   +13 more
europepmc   +1 more source

Exploring global health diplomacy in Iran: insights from experts in health and foreign policy. [PDF]

open access: yesBMJ Glob Health
Taghizade S   +5 more
europepmc   +1 more source

"It's like a reverse Robin Hood-We all know they can't pay": How court actors navigate the logics of monetary sanctions. [PDF]

open access: yesCriminology
Shannon S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy